Interleukin-1 Blockers: A Paradigm Shift in the Treatment of Recurrent Pericarditis

Interleukin-1 Blockers: A Paradigm Shift in the Treatment of Recurrent Pericarditis

Recurrent pericarditis is a problematic clinical condition that impairs the quality of life of the affected patients due to the need for repeated hospital admissions, emergency department visits, and complications from medications, especially glucocorticoids. Unfortunately, available treatments for...

Full description

Bibliographic Details
Main Authors: Emilia Lazarou, Christos Koutsianas, Panagiotis Theofilis, George Lazaros, Dimitrios Vassilopoulos, Charalambos Vlachopoulos, Costas Tsioufis, Massimo Imazio, Antonio Brucato, Dimitris Tousoulis
Format: Article
Language:English
Published: MDPI AG 2024-02-01
Series:Life
Subjects:
interleukin-1 blockers
recurrent pericarditis
steroid dependence
pathophysiology
NLRP3 inflammasome
Online Access:https://www.mdpi.com/2075-1729/14/3/305

Internet

https://www.mdpi.com/2075-1729/14/3/305

Similar Items